Browsing by Author Yiu, WH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 25 to 44 of 59 < previous   next >
TitleAuthor(s)Issue DateViews
 
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress
Journal:Kidney International
Yiu, WHWong, WLDWu, HLi, RYam, IYLChan, YYLeung, JCKLan, HYLai, KNTang, SCW
2016
85
 
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-Induced oxidative stress
Proceeding/Conference:Journal of the American Society of Nephrology
Yiu, WHWong, WLDWu, HLi, RChan, LYYLeung, JCKLan, HYLai, KNTang, SCW
2015
82
 
Lamivudine in hepatitis B-associated membranous nephropathy
Journal:Kidney International
Tang, SLai, FMMYun, HLTang, CSOKung, NNSYiu, WHKwok, WCLeung, JCKKar, NL
2005
197
 
Lipopolysaccharide Induces NEAT 1 Expression in AKI via TLR4/NF-κB Signaling
Proceeding/Conference:Journal of the American Society of Nephrology
XUE, RYiu, WHLOK, SWYChan, LYYLeung, JCKLai, KNLan, HYTang, SCW
2020
8
 
Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.
Journal:PLoS ONE
Wu, HJYiu, WHLi, RXWong, DWLLeung, JCKChan, LYYZhang, YLian, QLin, MTse, HFLai, KNTang, SCW
2014
70
 
Misaligned Expectations on Integrative Medical Service for Diabetes and Diabetic Kidney Disease – A Comparative Focus Group Series of Patients and Physicians
Proceeding/Conference:Global Advances in Health and Medicine
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLi, BLok, WYLi, HXue, RChan, YYLeung, JCKLam, TPLai, KNTang, SCW
2020
 
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice
Journal:Mediators of Inflammation
Chan, GCWYiu, WHWu, HWong, WLDLin, MHuang, XRLan, HYTang, SCW
2015
74
 
N-acetyl-seryl-aspartyl-lysyl-proline Mediates the Anti-fibrotic Properties of Captopril in Unilateral Ureteric Obstructed BALB/C Mice.
Journal:Nephrology
Chan, GCWWU, HCHAN, KWYiu, WHZou, WHuang, XRLan, HYLai, KNTang, SCW
2018
84
 
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study
Journal:BMC Complementary Medicine and Therapies
Chan, KWLee, PWLeung, CPSChan, GCWYiu, WHCheung, HMLI, BLOK, SWYLI, HXUE, RChan, LYYLeung, JCKLam, TPLai, KNTang, SCW
2020
37
 
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
Journal:Frontiers in Pharmacology
Chan, KWYu, KYYiu, WHXUE, RLOK, WYLI, HZOU, YMA, JLai, KNTang, SCW
2022
 
PRAgmatic Clinical Trial Design of Integrative MediCinE (PRACTICE): A Focus Group Series and Systematic Review on Trials of Diabetes and Kidney Disease
Journal:Frontiers in Medicine
Chan, KWLee, PWLeung, CPSLaw, YKGao, LChan, GCWYiu, WHLam, TPTang, SCW
2021
 
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling
Journal:Clinical Science
Yiu, WHLi, YLok, SWYChan, KWChan, LYYLeung, JCKLai, KNTsu, JHLChao, JHuang, XRLan, HYTang, SCW
2021
39
 
Protein overload induces renal proximal tubular epithelial cell apoptosis by down-regulating WNT/β-catenin signalling
Proceeding/Conference:Journal of the American Society of Nephrology
Wong, DWLYiu, WHWu, HLi, RLeung, JCKChan, LYYLai, KNTang, SCW
2013
 
Role of bone morphogenetic protein-7 (BMP7) in diabetic tubulopathy
Proceeding/Conference:Journal of the American Society of Nephrology
Li, RYiu, WHWu, HLin, MWong, DWLChan, LYYLeung, JCKLai, KNTang, SCW
2013
50
 
Role of bone morphogenetic protein-7 in renal fibrosis
Journal:Frontiers Physiology
LI, RYiu, WHTang, SCW
2015
59
 
Role of Renal Tubular Wnt/Beta-catenin in Proteinuric Kidney
Proceeding/Conference:Hong Kong Society of Nephrology Annual Scientific Meeting 2018
Yiu, WH
2018
6
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:International Congress of Chinese nephrologists
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLI, BLI, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
106
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Journal of the American Society of Nephrology
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2017
 
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
Journal:BMJ Open
Chan, KWIp, TPKwong, ASKLui, SLChan, GCWCowling, BJYiu, WHWong, DWLLiu, YFeng, YTan, KCBChan, LYYLeung, JCKLai, KNTang, SCW
2016
89
 
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial
Proceeding/Conference:Hong Kong Medical Journal
Chan, KWKwong, ASKLui, SLIp, TPChan, GCWCowling, BJYiu, WHWong, WLDLi, BLi, YFeng, YTan, KCBChan, YYLeung, JCKLai, KNTang, SCW
2018
94
Showing results 25 to 44 of 59 < previous   next >